FDA-Regulated Research

Similar documents
2014 Metrics on Human Research Protection Program Performance

Adventist HealthCare, Inc.

Guidance for Industry and Investigators Safety Reporting Requirements for INDs and BA/BE Studies- Small Entity Compliance Guide

Pre-Questions. Mastering Clinical Research July 29, 2015

Investigational Drugs: Investigational Drugs and Biologics

This policy applies to research administrators, investigators, research staff, Human Investigation Committee (HIC) members and HIC staff.

Guidance for Sponsors, Institutional Review Boards, Clinical Investigators and FDA Staff

Core Training Outline

Reliance Agreement for Institutions Utilizing Stony Brook University s Institutional Review Board(s)

Principal Investigator Responsibilities for Education and Social/Behavioral Researchers

RESEARCH INVOLVING DATA AND/OR BIOLOGICAL SPECIMENS

Human Research Protection Program Good Clinical Practice Guidance for Investigators Investigator & Research Staff Responsibilities

UNIVERSITY OF CALIFORNIA, SAN DIEGO HUMAN RESEARCH PROTECTIONS PROGRAM. DoD/DON-funded Research

PMAs, 510(k)s, and Advanced IDE Topics

Guidance for Sponsors, Investigators, and Institutional Review Boards. Questions and Answers on Informed Consent Elements, 21 CFR 50.

Regulatory Binder Instructions 25 April 2016

2 Applicability: Effective Date: 1/15/2010 Revised: 8/13/2010, 9/10/10, 5/9/14

Evaluation Instrument for Accreditation January 1, 2015

AAHRPP DOCUMENT # 84 UNIVERSITY OF ALABAMA HUMAN RESEARCH PROTECTIONS PROGRAM FORM: NOTIFICATION TO IRB OF EMERGENCY USE OF A TEST ARTICLE

STANDARD OPERATING POLICY AND PROCEDURE

Guide for Research Sites Seeking Accreditation

DHHS/NIH/OD/OIR/OHSRP 1/2/2015

Guidance for Industry

INVESTIGATOR HANDBOOK

The Regulatory Binder/Trial Master File: Essential Records for the Conduct of a Clinical Trial

INVESTIGATOR MANUAL. Table of Contents

Guidance on Withdrawal of Subjects from Research: Data Retention and Other Related Issues

Evaluation Instrument for Accreditation January 1, 2016

Minimum Education Requirements for DoD Personnel Involved in Human Research Protection

Principal Investigator and Sub Investigator Responsibilities

University of Hawai i Human Studies Program. Guidelines for Developing a Clinical Research Protocol

Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors

Policy on Human Subject Protection Training, Certification and Recertification at AUB

Department of Defense INSTRUCTION

Documentation of the Informed Consent Process. USC Office for the Protection of Research Subjects (OPRS)

Special Considerations for Pediatric Trials

Subject: No. Page PROTOCOL AND CASE REPORT FORM DEVELOPMENT AND REVIEW Standard Operating Procedure

WHEN I WANT TO: I NEED TO SUBMIT: {for CIRB studies, see the specific FAQ}

Investigator Handbook to Human Research Activities. South Shore Hospital

SAN DIEGO COMMUNITY COLLEGE DISTRICT INSTITUTIONAL REVIEW BOARD (IRB) INVESTIGATOR GUIDELINES FOR RESEARCH USING HUMAN SUBJECTS

Memorandum. Factual Background

CHAPTER 48 Bioresearch Monitoring

Comprehensive Study Documents List (Biomedical Studies)

Role of the Investigational Drug Services (IDS) in the Management of Investigational Drugs

OPERATING PROCEDURES

Use of Electronic Informed Consent in Clinical Investigations Questions and Answers Guidance for Industry

Guidance for IRBs, Clinical Investigators, and Sponsors

ROLE OF THE RESEARCH COORDINATOR Study Start-up Best Practices

Medical Billing and the Part A Fiscal Intermediary (HUD)

BUMC Clinical Research Seminar: What would YOU do? Put your IRB hat on!

PREP Course #27: Medical Device Clinical Trial Management

INSTITUTIONAL REVIEW BOARD

CenterWatch. volunteering. clinical trial. for a.

Clinical Investigator Inspections and FDA-483 Observations

Guidance for Industry and FDA Staff

Guidance for IRBs, Clinical Investigators, and Sponsors. Considerations When Transferring Clinical Investigation Oversight to Another IRB

Use of Electronic Health Record Data in Clinical Investigations

Guidance for Industry

12.0 Investigator Responsibilities

Guidance on the Genetic Information Nondiscrimination Act: Implications for Investigators and Institutional Review Boards

OECD Recommendation on the Governance of Clinical Trials

HIPAA Basics for Clinical Research

Guidance on IRB Continuing Review of Research

Human Subjects Research (HSR) Series

HIPAA Privacy Compliance Plan for Research. University of South Alabama IRB Guidance and Procedures

Expanded Access Programs. Richard Klein Office of Special Health issues Food and Drug Administration

Essential Standard Operating Procedures Sample Templates Table of Contents

DATA BREACHES: HOW TO AVOID THEM AND WHAT TO DO IF IT HAPPENS. Emory IRB Webinar January 8, 2015

Investigator-initiated clinical trials are

EVALUATION BRIEF Understanding the Institutional Review Board (IRB) January 2008

Human Subjects Research at OSU

11/10/2011. History of CBUs. 10-CBA providing access to unlicensed cord blood units. The FDA s involvement. The FDA s involvement, cont.

HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT (HIPAA): FACT SHEET FOR NEUROPSYCHOLOGISTS Division 40, American Psychological Association

Nova Southeastern University Institutional Review Board Policies and Procedures

Guidance on IDE Policies and Procedures

Clinical Investigator Training Course

Information Sheet Guidance for Sponsors, Clinical Investigators, and IRBs

Information Sheet Guidance For IRBs, Clinical Investigators, and Sponsors

Quality Considerations for Breakthrough Therapies-FDA Perspective

A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky

Information Technology &

U.S. Department of Health and Human Services (HHS) Registration of an Institutional Review Board (IRB)

Guidance for Industry and FDA Staff FDA Acceptance of Foreign Clinical Studies Not Conducted Under an IND Frequently Asked Questions

Flex Coalition Conference Call 6/21/13

O n Sept. 8, 2015, the U.S. Department of Health and

Mobile Medical Application Development: FDA Regulation

Medical Billing Human Research Studies Seminar Notes

Department of Health and Human Services. Final Guidance Document

Investigator responsibilities for research conducted under the authority of the UTHSCSA Institutional Review Board (IRB)

TRAINING AND EDUCATION

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV)

Cancer Clinical Trials: In-Depth Information

CTEP Workshop. An Overview of the NCI s Cancer Therapy and Evaluation Program (CTEP) CTEP s Mission. Workshop Objectives. NCI Organizational Structure

Classifying Adverse Events From Clinical Trials

Guidance on Reviewing and Reporting Unanticipated Problems Involving Risks to Subjects or Others and Adverse Events

Medical College of Georgia SOP NUMBER: 03 INVESTIGATIONAL DRUG HANDLING Version Number: 1.0, 1.1 Effective Date: 09/12/06, 08/02/10, 3/2/11

The Centers for Disease Control and Prevention (CDC 1 ) has issued the Human Research Protections Policy

Winthrop-University Hospital

Catherine Jahrsdorfer, RN, BSN Director of Clinical Services USF Health Office of Clinical Research

Using Social Media in Research: Regulatory and IRB Considerations

Transcription:

Research Compliance Office FDA-Regulated Research Jennifer S. Brown, RN IRB Education February 2008

Today s Topics FDA & OHRP integrated in HRPP What does FDA regulate? Scope of FDA regulations and comparison with OHRP Practical information for IRB members Resources January 2008 Research Compliance Office 2

Integrated within AAHRPP Element I.3.C. The Organization has and follows written policies and procedures for determining when studies meet the regulatory definitions of human research. Element I.3.F. The Organization includes in its Human Research Protection Program policies and procedures regarding the areas in which federal and state law differ, and provides guidance about regulatory compliance. Research Compliance Office 3

What does FDA regulate? FDA regulates Drugs, biologics & devices used in diagnosis, cure, mitigation, treatment or prevention of disease Clinical research that evaluates safety and effectiveness of FDA-regulated products (IND/IDE regulations) FDA approves (releases to market) products with labeling that summarizes safety and effectiveness, intended use & indications for use FDA exempts further clinical studies, that are conducted according to approved labeling, from IND/IDE regulations* All HS research with FDA-regulated products must undergo IRB review, even if exempt from IND/IDE regulations *Drug (IND) and device (IDE) regulations define and determine exemptions differently Research Compliance Office 4

Different Scope FDA (21 CFR 56.101) IRBs that review clinical investigations regulated by the FDA under sections 505(i), 507(d), and 520(g) of the act, as well as clinical investigations that support applications for research or marketing permits for products regulated by the FDA, including food and color additives, drugs for human use, medical devices for human use, biological products for human use, and electronic products. OHRP/HHS (45 CFR 46.101) All research involving human subjects conducted or supported by HHS or conducted in an institution that agrees to assume responsibility for the research in accordance with 45 CFR 46 regardless of the source of funding. Research Compliance Office 5

Major Similarities IRB membership requirements Event or UP reporting requirements IRB functions and operations IRB review of research, including expedited review procedures Criteria for IRB approval of research IRB records requirements General requirements for informed consent Research Compliance Office 6

Some Areas of Difference Definitions of human subjects, research, clinical investigation, sponsor, sponsorinvestigator, IRB Children s finding paragraph numbers Specific requirements for informed consent Emergency use, waivers, etc. Exemptions from IRB review Multi-institutional (FDA) and cooperative project (OHRP) projects Research Compliance Office 7

Some Definitions from FDA Human subject = An individual who is or becomes a subject in research as a recipient of a test article or as a control Clinical Investigation (research) = Any experiment that involves a test article and one or more human subjects that either... Meets requirements for prior submission to the FDA. IND IDE OR Need not meet requirements for prior submission to the FDA, but the results of which are intended NSR to be later submitted to, or held for inspection by, FDA as part of device off-label for marketing new use an application for a research or marketing permit. 510(k) application Research Compliance Office 8

Practical IRB Implications FDA Not allowed Waiver of documentation of consent (minimal risk) Not applicable Waiver of consent for military personnel OHRP Waiver or alteration of consent, waiver of assent or parental permission Waiver of documentation of consent (minimal risk) Waiver of documentation of consent (breach of confidentiality) Not applicable Consent document must state FDA may inspect records Emergency use of a test article Planned emergency research Not applicable Not applicable (Planned emergency research) Children s findings and paragraph numbers (light blue laminate) Children s findings and paragraph numbers (orange laminate) Research Compliance Office 9

References and Resources Comparison of FDA and HHS Human Subject Protection Regulations (FDA) http://www.fda.gov/oc/gcp/comparison.html Comparison of Regulations (OHRP) http://www.hhs.gov/ohrp/irb/irb_chapter2.htm#d7 Investigational New Drug Application (21 CFR 312) http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch. cfm?cfrpart=312 Investigational Device Exemptions (21 CFR 812) http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/cfrsearch. cfm?cfrpart=812 STANFORD HRPP, Chapter 5 Light blue and orange laminates Research Compliance Office 10